Monopar Therapeutics
MNPR
#8837
Rank
S$0.11 B
Marketcap
$22.39
Share price
7.31%
Change (1 day)
789.30%
Change (1 year)

EPS for Monopar Therapeutics (MNPR)

EPS in 2023 (TTM): -$1.05

According to Monopar Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.02. In 2022 the company made an earnings per share (EPS) of -$1.10 a decrease over its 2021 EPS that were of -$0.98.

EPS history for Monopar Therapeutics from 2017 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.05-4.66%
2022-$1.1012.16%
2021-$0.9827.59%
2020-$0.7743.71%
2019-$0.5433.52%
2018-$0.40-80.97%
2017-$2.11

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$2.89 183.12%๐Ÿ‡บ๐Ÿ‡ธ USA